Melvin
David H. Melvin, Toronto CA
Patent application number | Description | Published |
---|---|---|
20130337139 | Process and Composition for Making an Alcohol-Containing Frozen Comestible - A process for making an alcohol-containing frozen comestible substantially devoid of ice crystal agglomerations and/or ice crystal striations and/or trapped air and/or liquids is provided. The process includes substantially flash freezing an alcohol-containing liquid composition so as to produce a substantially single-phase solid alcohol-containing composition. The solid alcohol-containing composition, and/or pieces thereof, are then exposed to an environment having temperature of from about −15° C. to about −30° C. so as to soften the solid alcohol-containing compositions and/or meld the pieces thereof into a single mass. The temperature of the single mass is then reduced so as to harden the single mass. Also, a process for incorporating a frozen alcohol-containing liquid composition into a non-alcohol-containing fraction is provided. Alcohol-containing liquid compositions suitable for use in the process are also provided. | 12-19-2013 |
David Hart Melvin, Toronto CA
Patent application number | Description | Published |
---|---|---|
20100062134 | Alcohol based frozen dessert product - The present invention is directed to a single phase alcohol based frozen product. The single phase product is manufactured by introducing a premix, which includes alcohol, into a body of cryogen which freezes the premix rapidly. The single phased product does not include any liquid or gaseous components. The invention elevates the melting and fusing temperature of the pellets such that the storage temperatures of the pellets are similar to bulk frozen desserts. The invention may utilize the ingredients of bulk frozen desserts with the addition of alcohol. The invention is stable at retail and home freezer situations. The formulation and manufacture of the single phase product is different from bulk frozen desserts as well as other alcohol containing frozen products. The result is a product that maintains the desired individuality of the pellets while maintaining structure, such that fusing is inhibited at the storage and serving temperature. | 03-11-2010 |
20120128854 | Alcohol containing frozen dessert product - The present invention is directed to an alcohol containing bulk frozen dessert product that is formed by adding an alcohol containing composition to a frozen dessert product premix after the premix has been pasteurized. The alcohol containing composition is comprised of an alcohol, a water based mixer, and a stabilizer and/or emulsifier. The alcohol containing bulk frozen dessert product may have an alcohol content from about 2% to about 10% and will be able to be stored and consumed at temperatures for traditional bulk frozen dessert products. | 05-24-2012 |
D. Hart Melvin, Toronto CA
Patent application number | Description | Published |
---|---|---|
20100203214 | Frozen dessert product - The present invention is directed to formulations of the premix utilized in the production of a pellet structured frozen dessert type product. The pelletized frozen dessert product is manufactured by introducing the liquid premix into a body of a cryogen such as liquid nitrogen such that the small volume of liquid premix is frozen rapidly. The invention elevates the melting temperature as well as the fusing temperature of the finished pellets such that the storage and serving temperatures of the pellets are similar to the bulk products. The invention utilizes the basic formulas and names and flavors associated with bulk type frozen desserts such as Ice Cream, Sorbet, Water ice, Ice Milk, Frozen Yogurt and similar type products. The pellet produced utilizing the pre-mix is structurally stable at normal retail and home freezer situations. | 08-12-2010 |
Jonathan Melvin, Aughton GB
Patent application number | Description | Published |
---|---|---|
20150052220 | FILE TRANSFER USING XML - A tangible, machine readable storage medium stores instructions and implements a method when the instructions are executed by a processor. A source file is received by a gateway engine. The source file is a binary file. The source file is portioned into multiple parts by a breakdown engine. The multiple parts are transferred by a reliable transfer engine using a single port according to a messaging protocol to transfer messages reliably between nodes in the presence of any of software failures, component failures, system failures, or network failures. The multiple parts are reassembled into a copy of the source file by a reassembly engine. | 02-19-2015 |
William Melvin, Aberdeen GB
Patent application number | Description | Published |
---|---|---|
20090023160 | Antibodies specific for CYP1B1 - Antibodies that can specially bind to cytochrome P450 CYP1B1 and methods of making them are disclosed, in particular antibodies that bind to amino acid sequence VNQWSVNHDPVKWPN or PExFDPARFLDKDGy, where x is D or N and y is L or F, or an antigenic fragment thereof. The antibodies can be used in the diagnosis or treatment of cancers linked to enhanced CYP1B1 expression, including breast cancer, prostate cancer, colorectal cancer, liver cancer and ovarian cancer. | 01-22-2009 |
William Thomas Melvin, Aberdeen GB
Patent application number | Description | Published |
---|---|---|
20100216156 | CANCER MARKERS - Provided are previously uncharacterized markers of cancers, for example colorectal cancers, and uses of these as diagnostic and prognostic markers of cancers, and in particular colorectal cancers. The markers are SEQ ID NO:1—hnRNP-K; SEQ ID NO:2—HMG-1; SEQ ID NO:3—proteasome subunit alpha type 1; SEQ ID NO:4—bifunctional purine biosynthesis protein; SEQ ID NO:5—STI1; SEQ ID NO:6—annex in IV; SEQ ID NO:7—60 kDa heat shock protein; SEQ ID NO:8—T complex protein 1 beta subunit; SEQ ID NO:9—T complex protein 1 epsilon subunit; SEQ ID NO:10—mortalin; and SEQ ID NO:11—TER-ATPase. The invention further provides related methods and materials for the use of the markers in therapeutic intervention in colorectal and other cancers e.g. to specifically target neoplastic cells without causing significant toxicity in healthy tissues, and to provide methods for the evaluation of the ability of candidate therapeutic compounds to modulate the biological activity of cancerous cells from the colon, rectum and other tissues. | 08-26-2010 |